Delivery Order SPE2DB20D9135-SPE2DB25FZW80
Award Date
4/23/25
Potential Completion Date
5/14/25
Potential Value
$6.9K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,573.45 award is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive medical device, with a completion date of June 6, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,497.58, is for the delivery of 4,567,925,923 units of the NEXPLANON 68 MG IMPLANTS contraceptive device. The contract has an ultimate completion date of May 5, 2025 and was awarded on April 14, 2025. DMS Pharmaceutical Group Inc. also holds a larger $499,999,999...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a Firm Fixed Price delivery order worth $4,288.14 awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive device, with a performance period through October 21, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of pharmaceutical...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, awarded by the Defense Logistics Agency (DLA), is a firm fixed-price delivery order for the supply of NEXPLANON 68 MG IMPLANTS, a contraceptive product. The contract has a ceiling value of $12,583.60 and a completion date of June 27, 2022. This award is part of a larger indefinite delivery contract (IDC) between DMS...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $16,409.76 firm fixed-price contract is for 4,560,911,911 NEXPLANON 68 MG IMPLANTS, a contraceptive product. DMS Pharmaceutical Group is a key supplier to the DLA, holding a $499,999,999 Indefinite Delivery Contract for a comprehensive range of pharmaceutical items to support military healthcare facilities. This contract award is not...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $4,165.86 and provides for the delivery of 4,567,919,025 units of the NEXPLANON 68 MG IMPLANTS contraceptive product. The contract has an ultimate completion date of May 2, 2025 and was awarded on April 11, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $6,943.10, is for the delivery of 4,567,998,788 units of the contraceptive device NEXPLANON 68 MG IMPLANTS. The contract has an ultimate completion date of May 12, 2025 and was awarded on April 21, 2025. DMS Pharmaceutical Group Inc. is an established pharmaceutical wholesaler that has secured a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,082.93 contract is for the delivery of 4,567,950,199 units of NEXPLANON 68 MG IMPLANTS, a contraceptive product. The delivery order was awarded on April 14, 2025, with a period of performance through May 5, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $6,432.21 contract is for the delivery of 4,566,796,907 units of NEXPLANON 68 MG IMPLANTS, a contraceptive medication. The contract has a period of performance through January 17, 2025. DMS Pharmaceutical Group Inc. is the prime contractor and there are no noted subcontractors. The award is not associated with a specific set-aside...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,165.86 contract is for the delivery of 4,567,229,402 units of NEXPLANON 68 MG IMPLANTS, a contraceptive device, with a period of performance through March 3, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the...